Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

329 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Drug transporters in drug efficacy and toxicity.
DeGorter MK, Xia CQ, Yang JJ, Kim RB. DeGorter MK, et al. Among authors: kim rb. Annu Rev Pharmacol Toxicol. 2012;52:249-73. doi: 10.1146/annurev-pharmtox-010611-134529. Epub 2011 Sep 19. Annu Rev Pharmacol Toxicol. 2012. PMID: 21942630 Review.
In vitro and in vivo assessment of renal drug transporters in the disposition of mesna and dimesna.
Cutler MJ, Urquhart BL, Velenosi TJ, Meyer Zu Schwabedissen HE, Dresser GK, Leake BF, Tirona RG, Kim RB, Freeman DJ. Cutler MJ, et al. Among authors: kim rb. J Clin Pharmacol. 2012 Apr;52(4):530-42. doi: 10.1177/0091270011400414. Epub 2011 Apr 19. J Clin Pharmacol. 2012. PMID: 21505084 Clinical Trial.
Transporters and drug disposition.
Kim RB. Kim RB. Curr Opin Drug Discov Devel. 2000 Jan;3(1):94-101. Curr Opin Drug Discov Devel. 2000. PMID: 19649842
Intestinal drug transporter expression and the impact of grapefruit juice in humans.
Glaeser H, Bailey DG, Dresser GK, Gregor JC, Schwarz UI, McGrath JS, Jolicoeur E, Lee W, Leake BF, Tirona RG, Kim RB. Glaeser H, et al. Among authors: kim rb. Clin Pharmacol Ther. 2007 Mar;81(3):362-70. doi: 10.1038/sj.clpt.6100056. Epub 2007 Jan 10. Clin Pharmacol Ther. 2007. PMID: 17215845 Clinical Trial.
Organic anion-transporting polypeptide (OATP) transporter family and drug disposition.
Kim RB. Kim RB. Eur J Clin Invest. 2003 Nov;33 Suppl 2:1-5. doi: 10.1046/j.1365-2362.33.s2.5.x. Eur J Clin Invest. 2003. PMID: 14641549 Review.
Identification of functionally variant MDR1 alleles among European Americans and African Americans.
Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwarz UI, Taylor A, Xie HG, McKinsey J, Zhou S, Lan LB, Schuetz JD, Schuetz EG, Wilkinson GR. Kim RB, et al. Clin Pharmacol Ther. 2001 Aug;70(2):189-99. doi: 10.1067/mcp.2001.117412. Clin Pharmacol Ther. 2001. PMID: 11503014
OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine.
Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB. Cvetkovic M, et al. Among authors: kim rb. Drug Metab Dispos. 1999 Aug;27(8):866-71. Drug Metab Dispos. 1999. PMID: 10421612
Human MRP3 transporter: identification of the 5'-flanking region, genomic organization and alternative splice variants.
Fromm MF, Leake B, Roden DM, Wilkinson GR, Kim RB. Fromm MF, et al. Among authors: kim rb. Biochim Biophys Acta. 1999 Jan 8;1415(2):369-74. doi: 10.1016/s0005-2736(98)00233-8. Biochim Biophys Acta. 1999. PMID: 9889399
Molecular basis of ethnic differences in drug disposition and response.
Xie HG, Kim RB, Wood AJ, Stein CM. Xie HG, et al. Among authors: kim rb. Annu Rev Pharmacol Toxicol. 2001;41:815-50. doi: 10.1146/annurev.pharmtox.41.1.815. Annu Rev Pharmacol Toxicol. 2001. PMID: 11264478 Review.
Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments].
Fromm MF, Kim RB, Stein CM, Wilkinson GR, Roden DM. Fromm MF, et al. Among authors: kim rb. Circulation. 1999 Feb 2;99(4):552-7. doi: 10.1161/01.cir.99.4.552. Circulation. 1999. PMID: 9927403
329 results
Jump to page
Feedback